Effect of a quadrivalent meningococcal ACWY glycoconjugate or a serogroup B meningococcal vaccine on meningococcal carriage: An observer-blind, phase 3 randomised clinical trial

Effect of a quadrivalent meningococcal ACWY glycoconjugate or a serogroup B meningococcal vaccine on meningococcal carriage: An observer-blind, phase 3 randomised clinical trial

Показать другие версии (1)

Background Meningococcal conjugate vaccines protect individuals directly, but can also confer herd protection by interrupting carriage transmission. We assessed the effects of meningococcal quadrivalent glycoconjugate (MenACWY-CRM) or serogroup B (4CMenB) vaccination on meningococcal carriage rates...

Полное описание

Библиографические подробности
Главные авторы: Read, R, Baxter, D, Chadwick, DR, Faust, SN, Finn, A, Gordon, S, Heath, P, Lewis, D, Pollard, A, Turner, D, Bazaz, R, Ganguli, A, Havelock, T, Neal, K, Okike, I, Morales-Aza, B, Patel, K, Snape, MD, Williams, J, Gilchrist, S, Gray, S, Maiden, M, Toneatto, D, Wang, H, McCarthy, M
Формат: Journal article
Язык:English
Опубликовано: Lancet 2014
Описание
Итог:Background Meningococcal conjugate vaccines protect individuals directly, but can also confer herd protection by interrupting carriage transmission. We assessed the effects of meningococcal quadrivalent glycoconjugate (MenACWY-CRM) or serogroup B (4CMenB) vaccination on meningococcal carriage rates in 18-24-year-olds.

Схожие документы